2-四氢吡喃酸 | 51673-83-7

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡喃类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃
• 中文名称: 2-四氢吡喃酸
• 中文别名: 2-四氢吡喃甲酸
• 英文名称: tetrahydropyran-2-carboxylic acid
• 英文别名: tetrahydro-2H-pyran-2-carboxylic acid；(±)-tetrahydro-2H-pyran-2-carboxylic acid；2-tetrahydropyranic acid；oxane-2-carboxylic acid
• CAS: 51673-83-7
• 化学式: C₆H₁₀O₃
• mdl: MFCD07779239
• 分子量: 130.144
• InChiKey: MQAYFGXOFCEZRW-UHFFFAOYSA-N

物化性质

• 沸点：
  88-95 C
• 密度：
  1.1400 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2932999099
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P310,P312,P321,P330,P332+P313,P362,P403+P233,P405,P501
• 危险品运输编号：
  3265
• 危险性描述：
  H302,H315,H318,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Tetrahydropyran-2-carboxylic acid
Synonyms: Tetrahydropyran-2-yl-carboxylic acid

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H318: Causes serious eye damage
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: Tetrahydropyran-2-carboxylic acid
CAS number: 51673-83-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H10O3
Molecular weight: 130.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

合成方法

4-氧代-2-四氢吡喃酸（10克）溶于150毫升冰醋酸中，加入装有2克5% Pd/C的高压釜中，通入氢气，在0.4兆帕压力和75℃下反应，直至体系不再吸氢为止。通过薄层色谱（TLC）检测原料点消失后，冷却、过滤并旋蒸除去溶剂，得到黑色固体。然后用乙醚溶解该固体，并依次用水合碳酸钠萃取三次（每次150毫升），再用乙醚洗涤三次（每次150毫升）。酸化后进行过滤，最终获得白色固体。通过甲苯重结晶可得白色晶体2-四氢吡喃酸8.2克。

反应信息

• 作为反应物：
  描述：

  2-四氢吡喃酸 在 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 生成 四氢吡喃- 2 -羰基氯
  参考文献：
  名称：

  镍催化 α-氧乙酸硫酯的脱羰：硫醇的羟甲基化

  摘要：

  描述了镍催化α-羟基乙酸硫酯脱羰的策略，为单硫缩醛的合成提供了新途径，并进一步证明了氧原子可以稳定α-碳正离子并促进脱羰反应。该方法具有良好的官能团兼容性，可以耐受多种吸电子、电子中性和给电子取代基。此外，该方法补充了传统的交叉偶联反应。

  DOI：

  10.1055/a-2159-4369
• 作为产物：
  描述：

  四氢吡喃-2-甲醇 在 sodium hypochlorite 2,2,6,6-tetramethyl-piperidine-N-oxyl 、 甲基三辛基氯化铵 、 potassium bromide 作用下， 以 二氯甲烷 、 水 为溶剂， 生成 2-四氢吡喃酸
  参考文献：
  名称：

  对映选择性自由基还原和新的自由基时钟反应中的构象记忆

  摘要：

  酸 1 的自由基脱羧产生具有显着光学活性的四氢吡喃 3。这种手性的转移是构象记忆效应的一个例子，它来源于缓慢...

  DOI：

  10.1021/ja002068k

文献信息

• NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF
  申请人：FUJIFILM Corporation

  公开号：US20150322063A1

  公开（公告）日：2015-11-12

  A compound represented by Formula [1] (in the formula, Z 1 represents N, CH, or the like; X 1 represents NH or the like; R 1 represents a heteroaryl group or the like; each of R 2 , R 3 , and R 4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R 5 represents a heteroaryl group or the like) or salt thereof.

  由式[1]表示的化合物（在该式中，Z表示N、CH或类似物；X表示NH或类似物；R表示杂环烷基或类似物；R2、R3和R4中的每一个表示氢原子、卤原子、烷氧基或类似物；R5表示杂环烷基或类似物）或其盐。
• [EN] IRAK DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION D'IRAK ET LEURS UTILISATIONS
  申请人：KYMERA THERAPEUTICS INC

  公开号：WO2020264499A1

  公开（公告）日：2020-12-30

  The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety capable of binding to IRAK4 and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.

  本发明提供了化合物、其组合物以及使用这些化合物的方法。这些化合物包括能够结合到IRAK4的IRAK结合基团和诱导降解的基团（DIM）。DIM可以是DTM、一个连接酶结合基团（LBM）或赖氨酸类似物。这些化合物可以作为IRAK蛋白激酶抑制剂，并应用于IRAK介导的疾病。
• Macrocyclic MCL-1 inhibitors and methods of use
  申请人：AbbVie Inc.

  公开号：US20190055264A1

  公开（公告）日：2019-02-21

  The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).

  本公开提供了Formula (I)的化合物，其中A2、A3、A4、A6、A7、A8、A15、RA、R5、R9、R10A、R10B、R11、R12、R13、R14、R16、W、X和Y具有规范中定义的任何值，以及其药学上可接受的盐，可用作治疗疾病和病况的药物，包括癌症。还提供了包含Formula (I)化合物的药物组合物。
• Graphitic Carbon Nitride Polymer as a Recyclable Photoredox Catalyst for Decarboxylative Alkynylation of Carboxylic Acids
  作者：Jiaqi Guo、Yating Wang、Yuhang Li、Kailin Lu、Shihui Liu、Wei Wang、Yongqiang Zhang

  DOI：10.1002/adsc.202000777

  日期：2020.9.21

  Visible‐light‐induced heterogeneous photocatalysis for decarboxylative alkynylation has been performed. The using of cheap, metal‐free and recyclable graphitic carbon nitride (g‐C3N4) as the photoredox catalyst in the process enables the facile transformation of a variety of carboxylic acids into structurally diverse alkyne‐containing molecular architectures under mild and environmentally‐benign conditions

  可见光诱导的非均相光催化脱羧炔基反应。使用便宜，无金属且可回收的石墨氮化碳（g ‐ C 3 N 4）作为该过程中的光氧化还原催化剂，可以在温和和环境友好的条件下将多种羧酸轻松转化为结构多样的含炔分子结构。明显地，反应系统的非均质性质允许催化剂在多次运行中的回收和再利用而不损失反应性。光催化反应也可以以连续流动的方式进行并按比例放大至克级。此外，该策略在未活化烯烃的1，2氨基炔基化中的应用进一步凸显了该策略的制备能力。
• Compounds Which Modulate The CB2 Receptor
  申请人：Berry Angela

  公开号：US20100009964A1

  公开（公告）日：2010-01-14

  Compounds of formula (I) are disclosed. Compounds according to the and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

  公式（I）的化合物已被披露。根据该公式的化合物对治疗炎症有用。那些是激动剂的化合物还额外适用于治疗疼痛。